Susquehanna International Group’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $81.5K | Buy |
+13,237
| New | +$81.5K | ﹤0.01% | 5936 |
|
2024
Q1 | – | Sell |
-707
| Closed | -$9.57K | – | 6757 |
|
2023
Q4 | $9.57K | Buy |
707
+17
| +2% | +$230 | ﹤0.01% | 5742 |
|
2023
Q3 | $16.5K | Sell |
690
-551
| -44% | -$13.2K | ﹤0.01% | 5293 |
|
2023
Q2 | $39K | Buy |
1,241
+371
| +43% | +$11.7K | ﹤0.01% | 5256 |
|
2023
Q1 | $20.3K | Sell |
870
-619
| -42% | -$14.4K | ﹤0.01% | 5623 |
|
2022
Q4 | $28.9K | Buy |
+1,489
| New | +$28.9K | ﹤0.01% | 5285 |
|
2022
Q2 | – | Sell |
-421
| Closed | -$13K | – | 6793 |
|
2022
Q1 | $13K | Sell |
421
-333
| -44% | -$10.3K | ﹤0.01% | 5530 |
|
2021
Q4 | $29K | Buy |
+754
| New | +$29K | ﹤0.01% | 5576 |
|
2019
Q4 | – | Sell |
-302
| Closed | -$21K | – | 4942 |
|
2019
Q3 | $21K | Sell |
302
-321
| -52% | -$22.3K | ﹤0.01% | 4285 |
|
2019
Q2 | $80K | Buy |
+623
| New | +$80K | ﹤0.01% | 4201 |
|